Recent Updates
Recently added Catalysts
CTMX Positive Sentiment Score: 70/100

CytomX Therapeutics to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference

Key Takeaway: CytomX Therapeutics, a leader in localized biologics, will present at the H.C. Wainwright Immune Cell Engager Virtual Conference on August 17. CEO Sean McCarthy will lead the presentation, which will be accessible via live webcast. Additionally, CytomX management is set to hold one-on-one meetings with registered investors during the event.

Market Sentiment Analysis

POSITIVE FACTORS

  • CytomX Therapeutics is presenting at a prestigious conference.
  • The CEO's participation may enhance investor interest.
  • The event provides opportunities for one-on-one meetings with management.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will present at the H.C. Wainwright Immune Cell Engager Virtual Conference on Thursday, August 17 at 9:00 a.m. ET.
A live webcast of the fireside chat will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.
About CytomX Therapeutics
Probody is a U.S. registered trademark of CytomX Therapeutics, Inc.
SVP, Finance and Accounting
Investor and Media Contact:
Stern Investor Relations

Frequently Asked Questions

When will CytomX Therapeutics present at the virtual conference?

CytomX Therapeutics will present on August 17, 2023, at 9:00 a.m. ET.

Who will present at the H.C. Wainwright conference?

Sean McCarthy, D.Phil., CEO and chairman of CytomX, will present.

Where can I watch the live webcast of the presentation?

The live webcast will be available on CytomX’s Events and Presentations page.

Can investors schedule one-on-one meetings?

Yes, registered investors can have one-on-one meetings with management.

What trademark is associated with CytomX Therapeutics?

Probody is a registered trademark of CytomX Therapeutics, Inc.

Last updated: Aug 10, 2023